Technical420 Site Search

After leading Canadian Licensed Producers (LPs) announced quarterly financial results that came in lower than what many broker-dealers expected, several firms have issued new ratings and/or price targets on several LPs. Several of the price target decreases are substantial and we find the changes to be worth highlighting. We attribute…

Tilray, Inc. (TLRY: TSX) (TLRY: Nasdaq) tried to pull a fast one on the market and quietly reported quarterly financial results without a issuing a press release or holdings a conference call. After reading into the numbers, we are not surprised by Tilray’s decision to quietly announce its last quarterly…

The merger of the year is now complete… At a special shareholder meeting on April 30th, Tilray, Inc. (TLRY) shareholders voted in favor of a merger agreement with Aphria, Inc. (APHA.TO)(APHA), a leading Canadian Licensed Producer (LP). The closing of the transaction will result in the formation of a new…

Last week, Tilray, Inc. (TLRY) reported that it would reschedule the special shareholder meeting to take place April 30th and the change caught our attention.  At the meeting, Tilray shareholders will vote on the previously announced merger agreement with Aphria, Inc. (APHA.TO) (APHA) and we expect to see the transaction…

Earlier this week, Aphria Inc. (APHA.TO) (APHA) and Tilray (TLRY) launched a new website that combined the companies which comes ahead of a planned mega-merger. The development captured the attention of mainstream financial media firms and the combined company has been getting great coverage. Last week, we listened to a…

Earlier this week, Aphria Inc. (APHA.TO) (APHA) reported a major development as it relates to the European Union’s (EU) cannabis market and believes that our readers need to be aware of the significance of the announcement as it relates to the previously announced mega-merger with Tilray Inc. (TLRY). As standalone…

So far this year, Tilray Inc. (TLRY) has been one of the most highly talked about Canadian cannabis companies and we attribute the spike in interest to the pending mega-merger with Aphria Inc. (APHA.TO) (APHA). Following the merger announcement, Tilray surged to the upside as the market started to recognize…

Although Tilray Inc. (TLRY) reported strong fourth quarter financials and recorded a more than 20% increase in revenue when compared to the same period last year, broker-dealers have not responded as favorably as we anticipated. Following the earnings report, Tilray was downgraded by two broker-dealers and we found this to…

2021 is already proving to be a great year for the cannabis industry and Canada has been one of the greatest beneficiaries of this. So far this year, the merger between Aphria (APHA.TO) (APHA) and Tilray (TLRY) has been one of the most highly discussed topics and investors have been…

Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that it has received the necessary approvals and market authorization in accordance with the Portuguese legislation to offer Tilray medical cannabis products in Portugal from its GMP-certified EU facility in Cantanhede, Portugal. The market…